Delivery Order SPE2DB24D1104-SPE2DB25FYBD0

Award Date 5/19/25
Potential Completion Date 6/10/25
Potential Value $5K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,987.78 firm fixed-price contract is for the supply of BENLYSTA 200 MG/ML AUTOINJECTML, a medication used in the treatment of autoimmune diseases. The contract has an ultimate completion date of May 29, 2025 and is not set aside for any specific business category. AmerisourceBergen Drug Corp holds a significant...
This federal contract award, valued at $4,987.78, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order for the supply of BENLYSTA 200 MG/ML AUTOINJECTOR, a medication, with a performance period extending through May 22, 2025. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $4,987.78, is for the delivery of Benlysta 200 mg/mL autoinjector medication. It is a firm fixed-price, delivery order contract with a completion date of May 19, 2025. The contract is not set aside and is open to full and open competition. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of the medication BENLYSTA 200 MG/ML AUTOINJECTML. The contract has a firm fixed price of $6,165.34 and a period of performance ending on May 1, 2025. The award is not designated as a set-aside contract, indicating open competition. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of 200 mg/mL Benlysta autoinjectors. The $9,975.58 firm-fixed-price contract has a completion date of May 28, 2025. AmerisourceBergen holds a substantial $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which serves as a comprehensive global pharmaceutical support vehicle for military and other government...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,987.78 firm fixed-price delivery order is for the supply of BENLYSTA 200 MG/ML AUTOINJECTML, a medication. The contract has an ultimate completion date of June 6, 2025 and does not utilize a set-aside designation, indicating open competition. AmerisourceBergen Drug Corp holds a significant $999,999,999.00...
This is a $4,987.78 firm fixed price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of BENLYSTA 200 MG/ML AUTOINJECTML. The contract has an ultimate completion date of June 3, 2025 and is not set aside for any specific business category. Amerisourcebergen Drug Corp is the prime contractor on this award, which is a task order under the company's larger $999,999,999.00 Indefinite Delivery...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $6,165.34 firm fixed-price delivery order is for the supply of BENLYSTA 200 MG/ML AUTOINJECTML, a specialty medication. The contract has an ultimate completion date of April 15, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical through...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for $6,165.34 and has a period of performance through March 7, 2025. It is a firm fixed price contract to provide BENLYSTA 200 MG/ML AUTOINJECTML, a specialty medication, to support military healthcare programs. The award is associated with a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the supply of BENLYSTA 200 MG/ML AUTOINJECTOR. The contract has a firm fixed price ceiling value of $5,586.06 and an ultimate completion date of August 27, 2024. AmerisourceBergen, a major pharmaceutical distributor, was awarded this order as part of a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical valued up to $999,999,999 through December 2025 for delivering a...
  • SPE2DB24D1104
    Indefinite Delivery Contract
  • SPE2DB24D1104-SPE2DB25FYBD0
    Delivery Order

This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,987.78 firm fixed-price contract is for the supply of BENLYSTA 200 MG/ML AUTOINJECT medication, with a performance period through June 10, 2025. This award is not set-aside and represents open competition.

Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, designated as SPE2DX, which provides a comprehensive global pharmaceutical support vehicle through December 2026. This IDC enables the company to supply a wide range of pharmaceutical products and medical supplies to support military healthcare programs worldwide, including the Defense Health Agency and U.S. Coast Guard.

Generated 8/18/25, 9:58 AM